Diabetes

Tirzepatide noninferior, superior to semaglutide for T2DM

(HealthDay)—The dual glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptor agonist, tirzepatide, is noninferior and superior to semaglutide for reducing glycated hemoglobin levels among patients ...

Medications

Interleukin-1β inhibition linked to reduced incidence of anemia

(HealthDay)—Inhibition of interleukin-1β (IL-1β) with canakinumab is associated with reduced incident anemia as well as improved hemoglobin levels among patients with baseline anemia, according to research published online ...

Diabetes

The potentially deadly paradox of diabetes management

Diabetes affects nearly 1 in 10 adults in the U.S., of these millions, more than 90% have Type 2 diabetes. Controlling blood sugar and glycosylated hemoglobin levels—or HbA1c, which is sometimes referred to as A1C—is ...

Diabetes

Rates of diabetes screening high among adults age <45

(HealthDay)—Rates of diabetes screening are high, with hemoglobin A1c (HbA1c) used less but more likely to result in clinical diagnosis, according to a study published online Feb. 6 in Diabetes Care.

Health

Short duration between dinner, bed has no effect on HbA1c

(HealthDay)—Ensuring a short duration between dinner and bedtime has no effect on hemoglobin A1c (HbA1c) levels in middle-aged and older Japanese adults, according to a study published online Jan. 22 in BMJ Nutrition, Prevention ...

Diabetes

Long work hours tied to poor glycemic control in T2DM

(HealthDay)—Long work hours (≥60 hours/week) are associated with poor glycemic control in young Japanese men with type 2 diabetes, according to a study published in the January issue of the Journal of Diabetes Investigation.

page 1 from 9